fda3 min read
Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body
Current gene-editing treatments require removal of a participant’s cells, a complex and costly approach.
By Heidi LedfordNature AI

Read the full story
Originally published by Nature AI on Nov 12, 2026.
Comments
Sign in to join the discussion.